Carbamylated Erythropoietin Outperforms Erythropoietin in the Treatment of AKI-on-CKD and Other AKI Models

Erythropoietin (EPO) may be a beneficial tissue–protective cytokine. However, high doses of EPO are associate with adverse effects, including thrombosis, tumor growth, and hypertension. Carbamylated erythropoietin (CEPO) lacks both erythropoietic and vasoconstrictive actions. In this study, we compa...

全面介紹

Na minha lista:
書目詳細資料
發表在:J Am Soc Nephrol
Main Authors: Tögel, Florian E., Ahlstrom, Jon D., Yang, Ying, Hu, Zhuma, Zhang, Ping, Westenfelder, Christof
格式: Artigo
語言:Inglês
出版: American Society of Nephrology 2016
主題:
Basic Research
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC5084891/
https://ncbi.nlm.nih.gov/pubmed/26984884
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1681/ASN.2015091059
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍